About the Journal

What to Submit

Fact-based research papers on all facets of funding, distribution, regulation, marketing, promotion, and environmental impacts of vaccines are encouraged. Unbiased theoretical papers and well-designed empirical studies of efficacy and safety are welcomed. Contributors are encouraged to examine implications for national and international vaccination policies.

Contributions must be free of undisclosed “conflicts of interest”. The conflicts least commonly acknowledged, but most important to disclose, are those stemming from funding by corporate, pharmaceutical, or governmental agencies committed to outcomes favorable to vested interests that existed prior to the design, execution, and submission of the work for publication. Employees, consultants, and indirect beneficiaries of such funding past, present, or future must disclose any such relations even if they only seem to resemble potential conflicts of interest.

Theory and Research Ready for Peer-Review

Work presenting coherent theory, experimental findings, factual reports on current vaccine uses and policies, and civil debate within the scope of the journal as defined in our Jounal Summary are invited from all persons and entities — including those with disclosed vested interests. A vested interest in promoting one or many vaccines does not disqualify the contribution so long as those conflicting interests are plainly disclosed and the requirements of civility and scholarship are met. With all the foregoing in mind, the journal will only publish peer-reviewed articles consisting of Original Research, Reviews, Occasional Editorials (solicited or volunteered), Commentaries (examining one or several previously published articles in IJVTPR), and Letters to the Editor. However, all of the submissions should incorporate empirical research grounded in sound theoretical reasoning, including computer modeling if used, and must also cite the most relevant, and most up to date references from the best qualified peer-reviewed sources. Style preferred is Elsevier - Harvard (with titles). Except for the purpose of scholarly criticism, authors are advised not to cite any work  where undisclosed biases (e.g., owed to funding or other forms of sponsorship) are either known or reasonably suspected of being in play. Citations of blogs, websites, government agencies, or other sources that either lack a peer-review process or that are known to publish researchers with undisclosed pecuniary biases, are not acceptable unless flagged appropriately and critiqued. For the competent sources cited, relevant theories and experimental findings need to be adequately interpreted and explained in the submission. The reference list should include active hyperlinks to the URLs of all entries and these entries should also be hyperlinked to the in text reference: this approach can be used in MS Word and makes omissions of references in the text and list at the end of the article a thing of the past. Authors are urged to use an appropriate search engine to track down a DOI or URL for every entry in their Reference list.

Authors are free to offer hunches, inferences, and hypothetical conclusions based on their own best judgment, but such statements should not be based solely on opinion. Of course, legal opinions, in the technical sense, may be offered where appropriate and identified as such, but, in general, this journal does not solicit or accept mere opinion pieces. We will apply the Feynman rule: “It doesn’t matter how beautiful your theory is. It doesn’t matter how smart you are. If it doesn’t agree with experiment, it’s wrong.” Areas of interest may include, but are not limited to, the following:

  • disease conditions targeted for prevention (or not targeted, and why);
  • effects of adjuvants aiming to enhance the impact of active components of vaccines;
  • antiseptics, antibiotics, etc. incorporated to prevent unintended infections;
  • interactions of targeted and non-targeted pathogens in recipients of vaccines;
  • effects on microbiota, mitochondria, essential components of the CNS, etc.;
  • measured efficacy and risks of distinct delivery vectors, including recombinant DNA;
  • interactions with other medicines, supplements, and biophysical conditions;
  • lateral transmission of targeted pathogens to individuals or groups;
  • quality control in the manufacture of pathogens or components of vaccines;
  • measures of positive and/or negative impacts on immune defense systems;
  • epidemiological dynamics of the uptake of vaccines on diseases, deaths, and morbidity;
  • national and international vaccination policies in relation to any of the foregoing;
  • studies of vulnerable populations and their differential sensitivities to vaccines;
  • well-designed comparisons of vaccinated versus unvaccinated persons and groups;
  • computer modeling, theory, and empirical studies of the “herd immunity” doctrine;
  • critical examination of field-trials preceding licensing and distribution of vaccines;
  • historical, legal, and policy studies examining measured benefits and risks.

Letters and Commentaries

Letters and comments are invited on articles already published (and authors will be invited to respond, with no upper limit on the number of exchanges): for instance, citing additional relevant work, showing how to strengthen an experimental design or theoretical argument, suggesting a follow-up on original research, presenting compelling counter-evidence, and so forth.

Reviews and Editorials

Reviews and editorials may address any of the foregoing problematic issues. It is recommended that authors submitting work in these categories consult featured reviews by Cochrane to help them in constructing an acceptable article. The journal will also occasionally publish “book reviews” focusing on one or more books or monographs, but scholarly review articles and editorials should address issues of general interest to professional clinicians, researchers, policy-makers, and members of the general public. The objective of the IJVTPR is to make independent research, free from constraints of monetary, political, or any other undisclosed influence, about vaccine theory and practice freely accessible.


Legal Disclaimer

The information on this website, and whatever may appear in the IJVTPR, is not intended as a diagnosis, recommended treatment, prevention, or cure for any human condition or medical procedure that may be referred to in any way. Users and readers who may be parents, guardians, caregivers, clinicians, or relatives of persons impacted by any of the morbid conditions, procedures, or protocols that may be referred to, must use their own judgment concerning specific applications. The contributing authors, editors, and persons associated in any capacity with this website and with the journal disclaim any liability or responsibility to any person or entity for any harm, financial loss, physical injury, or other penalty that may stem from any use or application in any context of information, conclusions, research findings, opinions, errors, or any statements found on this website or in the IJVTPR. The material presented is freely offered to all users who may take an interest in examining it, but how they may choose to apply any part of it, is the sole responsibility of the viewer/user. If material is quoted or reprinted, users are asked to give credit to the source/author and to conform to the non-commercial, no derivatives, requirements of the Creative Commons License 4.0 NC ND.